MAY 07, 2016 8:33 AM PDT

First Safe Way to Target Drugs to the Placenta

WRITTEN BY: Xuan Pham
Image credit: Pixabay.com

For the first time, scientist demonstrate an effective way to deliver drugs to the placenta – a feat that’s almost impossible to accomplish without harm to the baby. Key to this discovery was the scientists’ realization that the placenta has properties similar to tumors, and thus, drug delivery mechanisms that work in tumors could also work for the placenta. The team hopes this proof-of-concept study will pave the way for future therapies to prevent premature births and other pregnancy-related complications.
 
The placenta is a complex organ that develops in the uterus of pregnant women. It attaches to the uterine wall, and provides oxygen and nutrients to the growing baby via the umbilical cord that extends from it. In addition, the placenta keeps waste products from accumulating in the baby’s blood.
 
Given the important roles, the health of the placenta is crucial to the well-being of both mother and baby. In some instances when the placenta is not functioning properly, doctors are forced to induce early delivery – a procedure that significantly raises the risks of infant mortality and related complications.

Drugs available to treat complications in utero are severely limited because of their potential harm to the growing baby. The difficulty remained: how to exclusively target the organ without side-effects to the nearby tissues. In this sense, the team of researchers realized the problem is much similar to treating tumors without collateral damage to the body.
 
"Placentas behave like well-controlled tumors," said Lynda Harris, researcher at the University of Manchester in England, and senior study author. "They grow quickly, produce growth hormones and evade the immune system. A lot of cancer research focuses on finding ways of delivering drugs to kill the tumor without affecting the rest of the body. We had the idea that if we could selectively target the placenta in the same way, we could deliver other drugs to help improve placental function and therefore treat pregnancy complications."
 
Indeed, they cloaked a growth hormone in tumor-homing peptides, which are short chains of simple amino acids. The peptides act as a chaperone to guide the drug to only the placenta organ. In mouse studies, the team showed this method was effective at increasing the growth of undersized fetuses. Additionally, the drug did not accumulate in the mother mouse’s organs nor the fetus, suggesting the drug was highly specific to only the placenta.
 
"Our findings emphasize the similarities between placentas and tumors," said Erkki Ruoslahti, a distinguished adjunct professor at UC Santa Barbara. "That similarity makes it possible to take some of the existing tumor-homing peptides and make use of them in targeting drugs to the placenta. This paper shows that it is possible to increase the delivery of drugs into the placenta via these peptides."
 
Of note, the study demonstrated proof-of-concept for the targeted delivery of drugs to the placenta based on methods established in cancer therapies. "Only one drug for use during pregnancy has been licensed in the last 20 years," said Harris. "By developing this platform, we have opened up the possibility that any number of new drugs can be adapted and then used safely to treat common and serious pregnancy complications."

Additional source: UC Santa Barbara press release

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 19, 2019
Cardiology
JUL 19, 2019
Heart Conditions Amongst The Most Misdiagnosed
There are a massive number of diseases that a person can acquire. This can make the idea of diagnosing a disease accurately seem like a daunting task. Shoc...
SEP 14, 2019
Chemistry & Physics
SEP 14, 2019
What is Photoacoustic Imaging?
In the last decade, photoacoustic tomography has slowly emerged as a versatile, radiation-free imaging modality that bears great potentials for basic resea...
SEP 18, 2019
Health & Medicine
SEP 18, 2019
Honey As An Antibacterial Against Methicillin-Resistant Staphylococcus Aureus
Honey has been used for its medicinal properties for thousands of years to treat wound infections, gastrointestinal ailments, and burns. Because of th...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Researchers Develop a Score to Quantify the Risk of Epilepsy
It usually takes two seizures before a person can be diagnosed with epilepsy. New work can help change that....
JAN 15, 2020
Clinical & Molecular DX
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a...
FEB 11, 2020
Clinical & Molecular DX
FEB 11, 2020
Portable device turns smartphones into diagnostic labs
Your smartphone lets you connect with friends, stores your memories, sends work emails and pays for your groceries. Soon, it could even help diagnose if yo...
Loading Comments...